featured-image

The motto “less is more” may have found some scientific backing when it comes to cancer treatments, according to reports that have recently emerged from the American Society of Clinical Oncology conference in Chicago, hailed as the world’s largest cancer conference. According to the , reports presented at the conference over the weekend showed that scaling back treatment for three types of cancer — ovarian, esophageal, and Hodgkin lymphoma — can improve patient quality of life without compromising outcomes. This reportedly includes conducting less surgery, or less radiation.

The study found that reducing these treatments could help patients live longer and feel better. It’s a far cry from nearly 30 years ago when the focus of cancer research was on increasing treatment intensity. A notable example involved women with advanced breast cancer undergoing extreme chemotherapy and bone marrow transplants, which proved no more effective than standard chemotherapy and caused significant suffering.



“The good news is that cancer treatment is not only becoming more effective, it’s becoming easier to tolerate and associated with less short-term and long-term complications,” said Dr. William G. Nelson from Johns Hopkins School of Medicine, who was reportedly not involved in the recent research.

According to the , in 2024, the United States is expected to see over 2 million new cancer cases. This translates to roughly 5,500 each day. The projects that more than 611,700 pe.

Back to Health Page